Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2407374
Max Phase: Preclinical
Molecular Formula: C31H41N3O6
Molecular Weight: 551.68
Molecule Type: Small molecule
Associated Items:
ID: ALA2407374
Max Phase: Preclinical
Molecular Formula: C31H41N3O6
Molecular Weight: 551.68
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](Oc1ccc(C=O)cc1)c1ccccc1)N1CN(C)[C@@H](CC(C)C)C1=O
Standard InChI: InChI=1S/C31H41N3O6/c1-20(2)16-25(31(38)39-6)32-29(36)27(34-19-33(5)26(30(34)37)17-21(3)4)28(23-10-8-7-9-11-23)40-24-14-12-22(18-35)13-15-24/h7-15,18,20-21,25-28H,16-17,19H2,1-6H3,(H,32,36)/t25-,26-,27-,28-/m0/s1
Standard InChI Key: FOFKTZSZENIWRZ-LJWNLINESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 551.68 | Molecular Weight (Monoisotopic): 551.2995 | AlogP: 3.84 | #Rotatable Bonds: 13 |
Polar Surface Area: 105.25 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.18 | CX Basic pKa: 3.95 | CX LogP: 4.76 | CX LogD: 4.76 |
Aromatic Rings: 2 | Heavy Atoms: 40 | QED Weighted: 0.30 | Np Likeness Score: 0.64 |
1. Mostardeiro MA, Ilha V, Dahmer J, Caro MS, Dalcol II, da Silva UF, Morel AF.. (2013) Cyclopeptide alkaloids: stereochemistry and synthesis of the precursors of discarines C and D and myrianthine A., 76 (7): [PMID:23819826] [10.1021/np400313w] |
Source(1):